• Record: found
  • Abstract: found
  • Article: not found

[Chlamydia trachomatis conjunctivitis in the newborn].

Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie

Primary Prevention, methods, Conjunctivitis, Inclusion, congenital, diagnosis, Chlamydia trachomatis, drug therapy, epidemiology, Diagnosis, Differential, Female, Fluorescent Antibody Technique, Humans, Infant, Newborn, Macrolides, Mass Screening, Polymerase Chain Reaction, Pregnancy, Prevalence, Anti-Bacterial Agents, therapeutic use

Read this article at

      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


      Infections of the conjunctiva are frequent in the neonatal period. While Neisseria gonorrhoea and chemical agents were considered as the main etiologies of ophtalmiae neonatorum in the past, Chlamydia trachomatis is today a major cause of neonatal conjunctivitis. Thus in a study of 180 uni-or bilateral neonatal conjunctivitis the authors found a prevalence of Chlamydia trachomatis infection of 41%. The importance of the etiological diagnosis of neonatal conjunctivitis is emphasized, in order to define a specific treatment. Etiological diagnosis of Chlamydia trachomatis infection is based upon immunofluorescence and molecular diagnosis techniques (PCR, LCR). Prevention of neonatal Chlamydia trachomatis conjunctivitis relies upon screening and treatment of Chlamydia trachomatis infections in pregnant women and their partners. Treatment requires oral macrolides, the topical treatment being ineffective.

      Related collections

      Author and article information



      Comment on this article